Insiders LIDDS AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 10:32:47 17/05/2024 BST			5-day change	1st Jan Change
0.16 ^SEK	-6.71%		-6.16%	+48.15%

05-14	LIDDS AB Announces CFO Changes, Effective 1 September 2024	CI
05-14	LIDDS AB Announces CEO Changes, Effective 1 September 2024	CI

LIDDS AB Announces CEO Changes, Effective 1 September 2024	05-14	CI
LIDDS AB Approves Board Elections	01-09	CI
Lidds AB Announces Resignation of Daniel Lifveredson from Board of Directors	12-07	CI
Lidds CFO to Take Over CEO Role; Shares Plunge	11-28	MT
LIDDS AB Announces CEO Changes	11-28	CI
LIDDS AB Announces CEO Changes	31/07/23	CI
Max Mitteregger Resigns from the LIDDS's Board	02/07/23	CI
Anders MÃ¥nsson Plans to Leave the LIDDS AB as CEO	27/06/23	CI
LIDDS AB Announces Management Changes	13/03/23	CI
Nomination Committee appointed for the Annual General Meeting 2023 in LIDDS	30/11/22	AQ
LIDDS AB Announces CEO Changes	15/07/22	CI
LIDDS AB Appoint Executives	07/07/22	CI
LIDDS AB Announces Board Changes	01/06/22	CI
LIDDS Appoints Matthew Lindon as Chief Scientific Officer, Effective March 1, 2022	20/12/21	CI
Nomination Committee appointed for the Annual General Meeting 2022 in LIDDS	17/11/21	AQ
LIDDS AB Announces Board Changes	17/11/21	CI
LIDDS AB Announces Appointment of Johan Harmenberg as Chief Medical Officer	15/11/21	CI
LIDDS AB Announces Management Changes, Effective April 19, 2021	15/12/20	CI
LIDDS Employs Charlotta Gauffin as Head of Clinical Development	06/02/19	CI
LIDDS Appoints Markus Thor as Head of Business Development and Will Join the in March 2019	10/01/19	CI

No results for this search